Safety Study of Infusion of SGT-53 to Treat Solid Tumors
Clinical trial NCT00470613 · COMPLETED
Trial details
- NCT number
- NCT00470613
- Sponsor
- SynerGene Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2016-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.